{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:51:38Z","timestamp":1791906698469,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bneo.2026.100294","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:24:18Z","timestamp":1787783058000},"page":"100294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Racial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-0149","authenticated-orcid":false,"given":"Anand","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0345-8267","authenticated-orcid":false,"given":"Christopher","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1485-5389","authenticated-orcid":false,"given":"Merry","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8159-4212","authenticated-orcid":false,"given":"Ankit S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10438","key":"10.1016\/j.bneo.2026.100294_bib1","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","volume":"403","author":"Silkenstedt","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bneo.2026.100294_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bjh.15224","article-title":"Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas","volume":"181","author":"Olszewski","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100294_bib3","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/s41598-021-82615-4","article-title":"Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma","volume":"11","author":"Yoshida","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.bneo.2026.100294_bib4","first-page":"136","article-title":"American Cancer Society\u2019s report on the status of cancer disparities in the United States, 2023","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.bneo.2026.100294_bib5","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1200\/JCO.23.00539","article-title":"Racial disparities in receipt of guideline-concordant care for early-onset colorectal cancer in the United States","volume":"42","author":"Nogueira","year":"2024","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.bneo.2026.100294_bib6","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","article-title":"Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.bneo.2026.100294_bib7","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2026.100294_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/cncr.34573","article-title":"Race, geography, and risk of breast cancer treatment delays: a population-based study 2004-2015","volume":"129","author":"Reeder-Hayes","year":"2023","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.bneo.2026.100294_bib9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/1055-9965.EPI-20-1728","article-title":"Disentangling racial, ethnic and socioeconomic disparities in treatment for colorectal cancer","volume":"30","author":"Obrochta","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.bneo.2026.100294_bib10","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1007\/s00277-024-06075-2","article-title":"Racial and ethnic disparities in outcomes of diffuse large B cell lymphoma in adolescent and young adults: a SEER database analysis","volume":"103","author":"Aqeel","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bneo.2026.100294_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.annepidem.2025.04.016","article-title":"Racial disparity in non-Hodgkin lymphoma: parallel survival analysis with data from the DoD central cancer registry and SEER","volume":"106","author":"Lin","year":"2025","journal-title":"Ann Epidemiol"},{"issue":"8","key":"10.1016\/j.bneo.2026.100294_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/10428194.2024.2338856","article-title":"The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the Veterans Health Administration (VHA)","volume":"65","author":"Ta","year":"2024","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.bneo.2026.100294_bib14","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the national cancer database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"issue":"22","key":"10.1016\/j.bneo.2026.100294_bib15","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/cncr.32378","article-title":"Race and delays in breast cancer treatment across the care continuum in the Carolina breast cancer stud","volume":"125","author":"Reeder-Hayes","year":"2019","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.bneo.2026.100294_bib16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bneo.2026.100294_bib18","doi-asserted-by":"crossref","first-page":"e0213209","DOI":"10.1371\/journal.pone.0213209","article-title":"Time to initial cancer treatment in the United States and association with survival over time: an observational study","volume":"14","author":"Khorana","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bneo.2026.100294_bib19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2010.31.2223","article-title":"Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network","volume":"29","author":"Proctor","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.bneo.2026.100294_bib20","doi-asserted-by":"crossref","first-page":"e2115675","DOI":"10.1001\/jamanetworkopen.2021.15675","article-title":"Trends in patient volume by hospital type and the association of these trends with time to cancer treatment initiation","volume":"4","author":"Frosch","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"16","key":"10.1016\/j.bneo.2026.100294_bib21","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/cncr.30038","article-title":"Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma","volume":"122","author":"Go","year":"2016","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.bneo.2026.100294_bib22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/jnci\/djaf011","article-title":"Changes in time-to-treatment initiation for breast, non-small cell lung, colon, or rectal cancers throughout the COVID-19 pandemic in the United States","volume":"117","author":"Fan","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"9880","key":"10.1016\/j.bneo.2026.100294_bib23","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(13)60313-X","article-title":"Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles","volume":"381","author":"Cunningham","year":"2013","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.bneo.2026.100294_bib24","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1200\/JCO.2017.76.5198","article-title":"Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials","volume":"36","author":"Maurer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bneo.2026.100294_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00432-017-2529-9","article-title":"Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries","volume":"144","author":"Augustin","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.bneo.2026.100294_bib26","first-page":"565","article-title":"Patient navigation across the cancer care continuum: an overview of systematic reviews and emerging literature","volume":"73","author":"Chan","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.bneo.2026.100294_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju115","article-title":"Impact of patient navigation on timely cancer care: the Patient Navigation Research Program","volume":"106","author":"Freund","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bneo.2026.100294_bib28","doi-asserted-by":"crossref","first-page":"OP2500805","DOI":"10.1200\/OP-25-00805","article-title":"Implementation of Suspected Cancer Initiative to Improve Cancer Diagnosis Timeliness in a Large Public Hospital System","author":"Thompson","year":"2026","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"10.1016\/j.bneo.2026.100294_bib29","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1200\/OP.22.00551","article-title":"Impact of an accelerated diagnostic assessment program on the timeliness of cancer diagnosis and treatment","volume":"19","author":"Bourkas","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2026.100294_bib30","first-page":"23","article-title":"Measuring and addressing health equity: an assessment of cancer center designation requirements","volume":"34","author":"Semprini","year":"2023","journal-title":"Cancer Causes Control"},{"issue":"26","key":"10.1016\/j.bneo.2026.100294_bib31","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1200\/JCO.2017.73.6546","article-title":"Charting the future of cancer health disparities research: a position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute","volume":"35","author":"Polite","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328026001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:30:46Z","timestamp":1791905446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328026001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950328026001056"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100294","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and socioeconomic differences in time to treatment initiation and outcomes in aggressive non-Hodgkin lymphoma","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100294"}}